Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | CDC25B | P30305 | 3/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10869821 | 0.91 | MEN1 (0.57) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL9754652 | 0.89 | ALDH1A1 (0.81) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL16340374 | 0.85 | MEN1 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL6441612 | 0.84 | CYP3A4 (0.56) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL39206 | 0.82 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL11525076 | 0.81 | MEN1 (0.42) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL9628778 | 0.81 | MEN1 (0.73) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL11399468 | 0.81 | AKR1C3 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL29570529 | 0.80 | KMT2A (0.72) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL6205557 | 0.80 | KMT2A (0.72) | KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160152554-A1 | METHOD FOR PRODUCING 2-(4-N,N-DIALKYLAMINO-2-HYDROXYBENZOYL) BENZOATES | DSM IP ASSETS B.V. (NL) | 2016-06-02 | — | — | US | claimed |
| EP-3013788-A1 | METHOD FOR PRODUCING 2-(4-N,N-DIALKYLAMINO-2-HYDROXYBENZOYL) BENZOATES | DSM IP Assets B.V. (NL) | 2016-05-04 | — | — | EP | claimed |
| WO-2014207002-A1 | METHOD FOR PRODUCING 2-(4-N,N-DIALKYLAMINO-2-HYDROXYBENZOYL) BENZOATES | DSM IP ASSETS B.V. (NL) | 2014-12-31 | — | — | WO | claimed |
| US-20050165099-A1 | Method for producing 2-(4-n,n-dialkylamino-2-hydroxybenzol)benzoates | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-28 | — | — | US | claimed |
| JP-2045568-A | — | — | None | — | — | JP | disclosed |
| JP-63230692-A | — | — | None | — | — | JP | disclosed |
| JP-11349831-A | — | — | None | — | — | JP | disclosed |
| JP-56109252-A | — | — | None | — | — | JP | disclosed |
| JP-9309272-A | — | — | None | — | — | JP | disclosed |
| US-9682920-B2 | Method for producing 2-(4-N,N-dialkylamino-2-hydroxybenzoyl) benzoates | DSM IP ASSETS B.V. (NL) | 2017-06-20 | — | — | US | disclosed |
| US-9682920-B2 | Method for producing 2-(4-N,N-dialkylamino-2-hydroxybenzoyl) benzoates | DSM IP ASSETS B.V. (NL) | 2017-06-20 | — | — | US | disclosed |
| US-9682920-B2 | Method for producing 2-(4-N,N-dialkylamino-2-hydroxybenzoyl) benzoates | DSM IP ASSETS B.V. (NL) | 2017-06-20 | — | — | US | disclosed |
| JP-S56109252-A | PRODUCTION OF FLUORAN DERIVATIVE | FUJI PHOTO FILM CO LTD | 1981-08-29 | — | — | JP | disclosed |
| US-4187193-A | Micro-capsules containing ureido fluoran chromogenic compounds | CHAMPION INTERNATIONAL CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
| US-4169183-A | 9-Dialkylamino-spiro [6H-[1]benzopyrano[3,2-g]quinoline-6,1'(3'H)-isobenzofuran]-3'-one compounds and pressure-sensitive recording system therewith | MOORE BUSINESS FORMS, INC. (US) | 1979-09-25 | — | — | US | disclosed |
| US-4110343-A | Bisfluoran chromogenic compounds, preparation thereof, and pressure-sensitive copy systems employing same | CHAMPION INTERNATIONAL CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
| US-4110343-A | Bisfluoran chromogenic compounds, preparation thereof, and pressure-sensitive copy systems employing same | CHAMPION INTERNATIONAL CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
| US-4104437-A | Pressure-sensitive copy system including ureido fluoran chromogenic compounds | CHAMPION INTERNATIONAL CORPORATION (US) | 1978-08-01 | — | — | US | disclosed |
| US-4012419-A | Bisfluoran chromogenic compounds, preparation thereof, and pressure-sensitive copy systems employing same | CHAMPION INTERNATIONAL CORPORATION (US) | 1977-03-15 | — | — | US | disclosed |
| US-4012419-A | Bisfluoran chromogenic compounds, preparation thereof, and pressure-sensitive copy systems employing same | CHAMPION INTERNATIONAL CORPORATION (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165099-A1 | Method for producing 2-(4-n,n-dialkylamino-2-hydroxybenzol)benzoates | ADH1C, ADH5, ADH1A | KMT2A 1310/4885MEN1 2986/4885SMN1; SMN2 4645/4885 |
| US-20160152554-A1 | METHOD FOR PRODUCING 2-(4-N,N-DIALKYLAMINO-2-HYDROXYBENZOYL) BENZOATES | HAAO, HAO2, HPD | KMT2A 1038/4885MEN1 3880/4885SMN1; SMN2 3951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.